Publicaciones en colaboración con investigadores/as de Institut d'Investigacions Biomèdiques August Pi i Sunyer (11)

2024

  1. Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1

    JHEP Reports, Vol. 6, Núm. 1

  2. Cirrhosis-downregulated LSECtin can be retrieved by cytokines, shifts the TLR-induced LSECs secretome and correlates with the hepatic Th response

    Liver International, Vol. 44, Núm. 4, pp. 996-1010

2023

  1. Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming

    Journal of Hepatology, Vol. 79, Núm. 3, pp. 728-740

  2. Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis

    Cell death & disease, Vol. 14, Núm. 8, pp. 514

2022

  1. Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy

    Cell death & disease, Vol. 13, Núm. 2, pp. 143

  2. Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 9, pp. 724-734

2021

  1. The Space of Disse: The Liver Hub in Health and Disease

    Livers, Vol. 1, Núm. 1, pp. 3-26

  2. Transcriptomic profiling of the liver sinusoidal endothelium during cirrhosis reveals stage-specific secretory signature

    Cancers, Vol. 13, Núm. 11

2020

  1. Animal models for liver disease – A practical approach for translational research

    Journal of Hepatology, Vol. 73, Núm. 2, pp. 423-440

2018

  1. Expression of microRNA-155 in inflammatory cells modulates liver injury

    Hepatology, Vol. 68, Núm. 2, pp. 691-706

2014

  1. Extracellular matrix and liver disease

    Antioxidants and Redox Signaling, Vol. 21, Núm. 7, pp. 1078-1097